30
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Steroidal Alkaloid Teratogens: Molecular Probes for Investigation of Craniofacial Malformations

&
Pages 303-326 | Published online: 28 Sep 2008
 

Abstract

Holoprosencephaly, a malformation sequence that results from impaired midline cleavage of the embryonic forebrain, is expressed as a spectrum of craniofacial anomalies of which cyclopia is the most severe. The Veratrum alkaloids are the most prominent of the teratogenic agents known to induce holoprosencephaly in mammals. Jervine and 11-deoxojervine (cyclopamine) are potent steroidal alkaloid teratogens from Veratrum californicum that are responsible for inducing cyclopic malformations in sheep.

Extensive structure-terata investigations of jervanes, solanidanes, and spirosolanes have shown that teratogenicity induced upon oral administration of all three structural types is significantly higher if the C-5, C-6 bond is unsaturated. Research in progress on the pathogenesis of holoprosencephalic malformations in both hamsters and humans offers the potential to provide information on the receptors involved in the expressions of these craniofacial syndromes. A clearer understanding of steroidal alkaloid-induced teratogenesis will emerge when appropriate receptor sites are revealed with which teratogenic alkaloids of slightly different structure can interact.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.